On June 15, ISDA and the European Banking Federation (EBF) submitted a response to ESMA’s consultation on post-trade risk reduction (PTTR). ISDA and the EBF stress that firms still have sizable bilateral portfolios and propose that transactions that are a result of PTRR should be allowed to remain uncleared, for derivatives transaction which would otherwise be subject to the clearing obligation (CO) under EMIR. In order to address concerns in relation to the potential risks of firms circumventing the CO, ISDA and the EBF propose strict conditions for administrative transactions resulting from PTRR. Therefore, PTRR should be performed by independent providers, there should be a requirement to prove that risk reduction exercises reduce the risk in each bilateral portfolio, and that each bilateral transaction resulting from PTRR exercises must be subject to an equal and opposite transaction facing a central counterparty.
Documents (1) for ISDA and EBF Respond to ESMA Consultation on PTRR Services with Regards to Clearing Obligation
Latest
Equity Definitions VE InfoHub
This page will be updated on a regular basis as relevant information becomes available and will serve as a repository for information from ISDA relating to the initiative to update the 2002 ISDA Equity Derivatives Definitions (the “2002 Equity Definitions”)....
ISDA responds to FSB on leverage in NBFI
On February 28, ISDA responded to the Financial Stability Board’s (FSB) consultation on leverage in the non-bank financial intermediation (NBFI) sector. In the response, ISDA makes the following points: Due to the diverse nature of the NBFI sector (in terms...
ISDA responds to BoE rules for FMIs
On February 19, ISDA submitted a response to a consultation from the Bank of England (BoE) on a proposal to introduce a set of rules for UK financial market infrastructures (FMIs), including central counterparties (CCPs). In the response, ISDA expresses...
Updated OTC Derivatives Compliance Calendar
ISDA has updated its global calendar of compliance deadlines and regulatory dates for the over-the-counter (OTC) derivatives space.